FluoretiQ

FluoretiQ develops rapid point-of-care diagnostic platforms, including the VERI-5 system, for bacterial identification and antibiotic sensitivity testing. The technology provides results within 15 to 30 minutes directly from samples, eliminating the need for traditional 3-day culture workflows. The company targets healthcare teams and veterinary practices to support antimicrobial stewardship and evidence-based prescribing in both human and animal health.